The Avita Medical share price just leapt 17%! What's going on?

Avita Medical shares are now up a whopping 110% in 2023.

| More on:
A group of science or medical professionals cheering good news in the lab.

Image source: Getty Images

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

The Avita Medical Inc (ASX: AVH) share price is having a banner day.

Shares in the ASX healthcare stock closed yesterday trading for $3.56. In morning trade on Tuesday, shares were swapping hands for $4.16, up a whopping 16.9%.

After what looks to be a bit of profit-taking, shares are currently trading for $4.06 apiece, up 14.04%.

With those gains factored in, the Avita Medical share price is up a stellar 110% in 2023.

For some context, the All Ordinaries Index (ASX: XAO) is up 0.64% today and up 1% year to date.

So, what's stirring investor interest in the regenerative medicine company today?

What's lifting the Avita Medical share price?

With no fresh price-sensitive news out from the ASX healthcare share, the Avita Medical share price looks to be rebounding from its 4% sell-down yesterday and continuing in line with Friday's 16.7% gains.

Friday's gains were spurred by the company's third-quarter update, with investors reacting positively to Avita's commercial revenue growth.

Commercial revenue increased 51% over the three months to reach US$13.5 million.

And investors weren't put off by the 48% increase in operating expenses, which saw Avita's net loss increase 55% to US$8.7 million over the quarter.

Investors may have shrugged off that loss because the company retained just over US$60 million cash on hand, which management said was enough to meet its profitability goals.

Crucially, Avita Medical CEO Jim Corbett anticipates the company will receive US FDA approval for its Recell Go product by mid-2024.

"We expect to submit a response to the FDA's open questions on February 28, 2024," Corbett said.

"Under the Breakthrough Device program, we anticipate FDA approval on May 30, 2024, which positions us for a launch the following day," he added.

That long-awaited FDA approval, should it come through, could offer some sustained tailwinds for the Avita Medical share price.

Motley Fool contributor Bernd Struben has no position in any of the stocks mentioned. The Motley Fool Australia's parent company Motley Fool Holdings Inc. has positions in and has recommended Avita Medical. The Motley Fool Australia has recommended Avita Medical. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

More on Share Gainers

A young man talks tech on his phone while looking at a laptop. A financial graph is superimposed across the image.
Share Gainers

Why Capricorn Metals, Insignia, Perseus Mining, and Qoria shares are storming higher

These shares are having a strong session on Tuesday. But why?

Read more »

A man clenches his fists in excitement as gold coins fall from the sky.
Share Gainers

Why Amaero, AMP, Block, and South32 shares are racing higher today

These shares are starting the week on a positive note. But why?

Read more »

Ten happy friends leaping in the air outdoors.
Share Gainers

Here are the top 10 ASX 200 shares today

It was another momentous session for ASX shares this Friday.

Read more »

Overjoyed man celebrating success with yes gesture after getting some good news on mobile.
Share Gainers

Why BHP, Catalyst Metals, Mesoblast, and Pilbara Minerals shares are shooting higher

These shares are ending the week with a bang. But why?

Read more »

Doctor doing a telemedicine using laptop at a medical clinic
Healthcare Shares

The Mesoblast share price just rocketed 38%! Here's why

ASX investors just sent the Mesoblast share price up 38%. But why?

Read more »

A businessman stacks building blocks.
Share Gainers

Here are the top 10 ASX 200 shares today

ASX shares hit a new record high today.

Read more »

A man sees some good news on his phone and gives a little cheer.
Share Gainers

Why Auckland Airport, Australian Ethical, Breville, and Clarity shares are charging higher

These shares are having a better day than most on Thursday. But why?

Read more »

A man sits on a bench atop a mountain with a laptop, making investments with a green ESG mind.
Share Gainers

Here are the top 10 ASX 200 shares today

Investors endured a day to forget this hump day.

Read more »